Conclusion

Lawton Robert Burns (burnsl@wharton.upenn.edu)
Additional contact information
Lawton Robert Burns: The Wharton School, University of Pennsylvania

Chapter Chapter 14 in The Healthcare Value Chain, 2022, pp 617-638 from Springer

Abstract: Abstract Chapter 1 alerted readers that they were about to enter “dark territory.” The allegations leveled against GPOs and/or PBMs included: monopoly power and anticompetitive behavior, collusion with manufacturers, exclusive contracts, market foreclosure of small and innovative firms, impeded patient access to needed technologies, conflicts of interest, excessive fees and outsized profits, kickbacks and secret rebates, lack of transparency and full disclosure, artificially high product prices, reduced provider discretion in decision-making, harms to patient care and quality, and higher consumer costs.

Date: 2022
References: Add references at CitEc
Citations:

There are no downloads for this item, see the EconPapers FAQ for hints about obtaining it.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:spr:sprchp:978-3-031-10739-9_14

Ordering information: This item can be ordered from
http://www.springer.com/9783031107399

DOI: 10.1007/978-3-031-10739-9_14

Access Statistics for this chapter

More chapters in Springer Books from Springer
Bibliographic data for series maintained by Sonal Shukla (sonal.shukla@springer.com) and Springer Nature Abstracting and Indexing (indexing@springernature.com).